Organic anion transporting polypeptide OATP1B3 is a membrane-bound drug transporter that facilitates cellular entry of a variety of substrates. Most of the previous studies focused on its hepatic expression and function in hepatic drug elimination. In this study, we report expression of OATP1B3 in human pancreatic tissue, with the abundance of the transporter localized in the islets of Langerha...

OBJECTIVE To evaluate whether treatment with insulin in recently diagnosed type 2 diabetes is advantageous compared with glibenclamide treatment. RESEARCH DESIGN AND METHODS Beta-cell function, glycemic control, and quality of life were monitored over 2 years in 39 patients with islet cell antibody-negative type 2 diabetes diagnosed 0-2 years before inclusion in a Swedish multicenter randomiz...

An investigation into the suitability of mucuna gum microspheres for oral delivery of glibenclamide is presented. Mucuna gum microspheres were formulated under different conditions of polymer concentration and crosslinking time at constant speed. The formulated microspheres were thereafter loaded with glibenclamide by the remote loading process. The microspheres were evaluated according to part...

BACKGROUND Metformin is widely used to treat gestational diabetes (GDM), but many women remain hyperglycaemic and require additional therapy. We aimed to determine recruitment rate and participant throughput in a randomised trial of glibenclamide compared with standard therapy insulin (added to maximum tolerated metformin) for treatment of GDM. METHODS We conducted an open label feasibility s...

BACKGROUND To observe the influence of combination treatment with glibenclamide and CoCl(2) on the growth and invasiveness of TA2 breast cancer, and to detect the protein and mRNA expression of MMP9. METHODS 50 adult female TA2 mice were randomly divided into 5 groups including DMSO control, CoCl(2), glibenclamide, CoCl(2) + glibenclamide and paclitaxel. All of these mice were inoculated with...

background: untreated or poorly controlled gestational diabetes can cause serious complications for mother and newborn. glibenclamide is rarely used in treating mothers with this disease. this study aimed at comparing the effect of glibenclamide and insulin on neonatal outcomes in women with gestational diabetes mellitus. methods: in this randomized controlled clinical trial, 249 pregnant women...

apatient was admitted to the hospital because of epistaxis, ecchymoses and gum bleeding with inr of 5.5. this patient had a known case of diabetes mellitus type ii, 5 years ago. the last dose of glibenclamide for managing signs and symptoms of diabetes mellitus was 20 mg/day. her medical history also showed that last month she was diagnosed with atrial fibrillation with normal left ventricular ...

background: to evaluate the efficacy of adding the glutazone to maximum dose of sulfonylurea and metformin in patients with poorly controlled type 2 diabetes. methods: ninety six patients with type 2 diabetes who had failed medical therapy with maximal-dosage of metformin and glibenclamide received glutazone. fasting blood sugar (fbs), 2 hours postprandial (2hpp) glucose, hemoglobin a1c, choles...

To study the mechanisms of glibenclamide actions on volume-sensitive Cl-channels, whole cell patch-clamp studies were performed at various pH levels in human epithelial Intestine 407 cells. Extracellular application of glibenclamide reversibly suppressed volume-sensitive Cl- currents in the entire range of voltage examined (-100 to +100 mV) and accelerated the depolarization-induced inactivatio...

Diabetes mellitus is a chronic metabolic disorder and becoming the world’s third “killer” together with cancer, cerebro cardiovascular diseases due to its wide spread prevalence, morbidity mortality. Modern anti-diabetic agents produce undesirable adverse effects. As result, alternative therapy required. A shift towards marine natural products desperately needed. Hence, this research was carrie...